Proteome award
Dr Alexander Makarov, Thermo Fisher Scientific director of global research for life sciences mass spectrometry, has received the first HUPO Science and Technology Award from the Human Proteome Organization (HUPO) at the HUPO 2011 10th World Congress in Geneva, Switzerland.
Dr Alexander Makarov, Thermo Fisher Scientific director of global research for life sciences mass spectrometry, has received the first HUPO Science and Technology Award from the Human Proteome Organization (HUPO) at the HUPO 2011 10th World Congress in Geneva, Switzerland. The award honours Dr Makarov’s principal role in developing the Orbitrap mass analyser.
“We are extremely pleased to see Alexander receive this award, and we are grateful to HUPO for recognizing him in this way,” said Greg Herrema, senior vice president and president, analytical instruments group, Thermo Fisher Scientific. “We are proud of the contributions that Orbitrap mass spectrometers have made to scientific knowledge in proteomics, metabolomics, metabolism and many other fields, and Alexander continues to play an important role in the advancement of Orbitrap technology.”
Dr Makarov, who has authored more than 40 papers and holds more than 40 patents worldwide, first presented the Orbitrap mass analyser in a paper published in 2000. Orbitrap-based mass spectrometers are reported to offer performance that was previously only available from Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass spectrometers, enabling more widespread use of ultra-high resolution and high mass accuracy instrumentation.
For more information about the technology and mass spectrometers visit www.planetorbitrap.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
